Biocept Announces a Delay in the Filing of its Quarterly Report on Form 10-Q

(Nasdaq: BIOC), a leading provider of molecular diagnostic assays, products, and services, announces a delay in the filing of its Quarterly Report on Form 10-Q for the quarter ended June 30, 2022.